According to our latest research report, “Russian Pharma Sector Forecast to 2013”, the prevalence of diabetes has been steadily increasing in Russia over the past few years. Due to rapid adoption of modern ways of living, the Russian insulin market grew at a CAGR at around 14% during 2007-2010, opening an exciting market for insulin manufacturers. Increase in diabetic population, despite the fact that the overall Russian population is decreasing, implies that there will be a sharp rise in the prevalence of diabetes in the country in near future. This will lead to the growth in anti-diabetic medicines, especially insulin, in the country.
Besides, we have conducted thorough research and prudent analysis of Russian Pharma market and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that the growth of the industry will be mainly driven by dynamic government support and increasing private investments. Further, various factors such as growing healthcare spending and growth in the obligatory and voluntary insurance schemes have been resulted in the increasing usage of high-priced drugs in the country as well.
Our study indicates that infectious diseases like HIV/AIDS are on the rise and Russia is transforming a more conducive environment for clinical trials which will further pave the way for the growth of the pharmaceutical industry in the country. Our research unfolds various other drivers that would safeguard and promote the further growth of the industry.
Our report “Russian Pharma Sector Forecast to 2013” provides precise and reliable information, supplemented with statistics, regarding the Russian pharma sector. The report covers leading drugs, segment-wise break up, and information about major therapy areas. It has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecasts are also carried out considering the possible impact of recession on the industry. The report presents a brief overview of demographics and healthcare profile to adjudge the pharmaceutical market in terms of demands, expenditure, and possible future direction.
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.